Global Post-traumatic Stress Disorder Therapeutics Market

1
Global Post-traumatic Stress Disorder
Therapeutics Market 2015-2019
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast 2019
Published Date Jun 2015
2
Report Description
About PTSD PTSD is a psychological condition
that develops after a person is exposed to any
traumatic event, and it drains a person
emotionally. According to the DSM-IV codes found
in the Diagnostic and Statistical Manual of
Mental Disorders, published by the American
Psychiatric Association (APA) , PTSD is
classified under anxiety disorders. PTSD can
occur in individuals of any age, irrespective of
the gender its symptoms can develop immediately
after a traumatic event or during the course of
time. Its symptoms normally include re-experience
of the traumatic event, avoidance of the
incidents, and abnormal mood swings. Treatments
for PTSD include psychological counselling, which
help in identifying the cause of the condition
and providing counselling to come out of the
situation. Medications present in the market help
in reducing the symptoms during the course of the
treatment. The global PTSD therapeutics market
to grow at a CAGR of 1.09 over the period
2014-2019 Get Complete Report At http//www.bigm
arketresearch.com/global-post-traumatic-stress-dis
order-therapeutics-2015-2019-market
3
Report Description
Covered in this Report This report covers the
present scenario and the growth prospects of the
global PTSD therapeutics market for the period
2015-2019. To calculate the market size, the
report considers revenue generated from the sales
of various generic, off-label, and branded
therapies used for the treatment of PTSD. This
report includes the segmentation of the market
based on geography. Key Regions Americas
APAC EMEA Key Vendors GlaxoSmithKline
Pfizer Otsuka Pharmaceutical Enquire About
this report http//www.bigmarketresearch.com/repo
rt-enquiry/250701
4
Report Description
Other Prominent Vendors Azevan
Pharmaceuticals Baylor Research Institute
Eli Lilly Forest Laboratories H. Lundbeck
Humanetics Pharmaceuticals Marinus
Pharmaceuticals Nanotherapeutics Neurocrine
Biosciences Novartis Pharmaceuticals
Synchroneuron Tonix Pharmaceuticals Market
Driver Growing Number of Accidents and Violence
Worldwide For a full, detailed list, view our
report Market Challenge Unavailability of
Standard Diagnostic Methods For a full,
detailed list, view our report
5
Report Description
Market Trend Rise in Public Awareness For a
full, detailed list, view our report Key
Questions Answered in this Report What will the
market size be in 2019 and what will the growth
rate be? What are the key market trends? What
is driving this market? What are the challenges
to market growth? Who are the key vendors in
this market space? What are the market
opportunities and threats faced by the key
vendors? What are the strengths and weaknesses
of the key vendors?
6
Table of Contents
01.Executive Summary 02.List of
Abbreviations 03.Scope of the Report 04.Market
Research Methodology 05. Product Profiles 06.
Introduction 07. PTSD Overview 08. Pipeline
Analysis 09. Market Landscape 10. Market
Segmentation by Class of Drug 11. Geographical
Segmentation 12. Buying Criteria 13. Market
Growth Drivers 14. Drivers and Their Impact 15.
Market Challenges 16. Impact of Drivers and
Challenges 17. Market Trends 18. Trends and Their
Impact 19. Vendor Landscape
7
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/global-post-traum
atic-stress-disorder-therapeutics-2015-2019-market

Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone]E-MAIL
help_at_bigmarketresearch.com